Home Infusion Therapy Devices Market Snapshot
Home Infusion Therapy Devices Market is anticipated to register a Y-o-Y increase of 5.3% and reach US$ 2.0 Bn by 2021. As per Future Market Insights (FMI), the infusion system accessories are expected to account for over 45% sales in the market.
Regionally, North America will dominate the global home infusion therapy devices market, accounting for over 31% of demand. Global valuation of the market is expected to total US$ 3.8 Bn by the end of 2031.
Key Points Covered in Home Infusion Therapy Devices Market Study
- Historical Home Infusion Therapy Devices Market Assessment (2016-2020)
- Future Demand Outlook for 2021-2031
- Driver and Restraints Analysis
- Home Infusion Therapy Devices Market: Segment-wise Analysis
- Market Share Analysis of Key Vendors
- Recommendation for Winning Strategies
2016-2020 Home Infusion Therapy Devices Demand Outlook Compared to 2021-2031 Forecast
The global home infusion therapy devices market expanded at over 5.3% CAGR in 2021. Driven by increasing sensitivity of people towards orally administered medicines and rising prevalence of GI-related disorders, the market is poised to expand at 6.5% CAGR through 2031.
As patients now prefer shorter stay in hospitals and due to the outbreak of COVID-19, the demand for home infusion therapy has considerably increased. Slow administration of drugs, antibiotics in hospitals and risk of getting infection are the major reasons for improved adoption of home infusion therapy devices.
It is also considered a more preferred choice for the treatment of cancer and GI-related diseases or any medical condition when orally administered medicines are not working. Approximately, 33% of cancer survivors have chronic pain and need infusion therapy and direct administration of drugs for rapid relief.
Due to the increasing preference among patients and high prevalence of cancer across the globe, the home infusion therapy devices market is expected to grow rapidly during the forecast period.
The market is expected observe an incremental $ opportunity of more than US$ 1.7 Bn through 2021 & beyond.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Key Factors Improving Revenue for Market Players?
Rising acceptance for speciality infusion therapy presents strong growth opportunities for manufacturers. It is a specific type of infusion therapy that involves the administration of medication using speciality medical infusion pumps, designed to accommodate a particular type of fluid or medication.
Among all the products types, insulin pumps are expected to show the maximum growth, exhibiting growth at a CAGR of 8.2% during 2021-2031. Rising prevalence of diabetes across the globe is improving the demand for insulin pumps.
According to the National Health Service (NHS) U.K., incidence of diabetes have increased by approximately 60% over the past decade.
Rising cases of chronic diseases such as diabetes and cancer are improving the adoption of these devices. This will in turn create attractive opportunities for home infusion therapy devices manufacturers.
What are the Factors Restraining Home Infusion Therapy Devices Market Growth?
Infusion pumps are one of the most recalled medical devices which lead to the risk of medical errors and might harm the patients’ health. Most common errors related to infusion pumps are software problems, alarm errors, damaged components, battery failure, sparks, or electric shocks.
For instance, in March 2021, BD’s Alaris infusion pump Model 8100 was recalled. According to the Food and Drug Administration (FDA), there were a total of 62 complaints reported about the device and one death may have been related to this recall.
What is the Impact of the COVID-19 on the Market?
COVID-19 is anticipated to have a moderately positive impact on the home infusion therapy devices market due to the rising cases of chronic diseases. The symptoms of chronic diseases such as diabetes can get severe on encounter with SARS-COV2.
Demand for home-based treatments increased amidst COVID-19, as patients were sensitive about the risk of getting infected in hospitals. Also, demand for home infusion therapy devices propelled to reduce the rate of COVID-19 infection by avoiding the hospitals.
Will the U.S. Remain a Lucrative Home Infusion Therapy Devices Market?
The U.S. is the expected to be the leading country of North America , accounting for a total market share of 91% in 2021. The U.S. market is expected to continue experiencing high growth during the coming years. Growth of this market is mainly driven by the rising prevalence of chronic diseases such as diabetes.
For instance, according to Centers for Disease Control and Prevention (CDC), in 2018, there were approximately 34.2 million cases of diabetes found among the U.S. population. Backed by the rising cases of diabetes and patients preference to stay at home for better care, sales of home infusion therapy devices are expected to spur.
How is Germany Spearheading the Growth in the Europe Market?
Germany is expected to dominate the Europe home infusion therapy devices market, with the leading share of 20% throughout the forecast period. Increasing healthcare spending as a result of the rising awareness about health and wellness has resulted in improved demand for these devices.
Among all the European countries, Germany spent the maximum on its healthcare system that is approximately 11% of the GDP in 2018, according to Eurostat.
Besides this, presence of key players in the country and increasing investment on medical devices are aiding market growth.
For instance, Fresenius Kabi AG, in 2018, announced that it had invested US$ 2.0 million in the Israeli medical device company named Vectorious Medical Technologies.
Why is Japan an Emerging Market for Home Infusion Therapy Devices?
Japan holds over 38% share in the East Asia market and is projected to expand at a CAGR of 6.8% in 2021. Key companies are eyeing at Japan since technological development in the country’s healthcare industry is increasing.
Leading companies are collaborating and acquiring local healthcare manufacturers in Japan to expand their product portfolio and customer base. This in turn will drive the home infusion therapy devices market.
For instance, in February 2021, Terumo Corporation announced its agreement to acquire Health Outcomes Sciences, Inc. which expands Terumo's presence in the digital healthcare sector and offers a great opportunity to grow in the future.
What is the Outlook in China for the Home Infusion Therapy Devices market?
In 2020, China dominated the East Asia market with more than 52% share and is projected to expand at a CAGR of 7.9% during the assessment period. This is primarily due to the rising surgical procedures such as total knee replacement and total hip replacement.
To avoid the post-operation pain and risk of other infection, patients are opting for home infusion therapy devices. As pain and surgeries are more common in geriatric population, adoption of these devices are expected to increase in the country.
Which Product Type Accounts for Maximum Sales?
Based on product type, the insulin pump segment is expected to expand at a CAGR of 8.7% during the forecast period from 2021 to 2031.
People suffering from diabetes are tired of insulin injections and want to get relief from the pain. Hence, adoption of an alternative method known as an insulin pen has increased. Insulin pumps help diabetes patients in managing their blood sugar. It is a small device that delivers insulin doses at specific times.
Why does the Antibiotic Administration Hold a High Market Share?
In terms of application, antibiotic administration dominated the home infusion therapy devices market. With contributing over 34% of the revenue share in 2021, the segment is expected to exhibit the highest growth.
Growth in this segment is attributed to the growing demand for antibiotics due to the rising bacterial infections and rising prevalence of chronic diseases.
Who is the Leading End User of Home Infusion Therapy Devices?
Based on the end user, the home care settings segment is dominating the market, accounting for more than 70% of sales. Growing awareness about home infusion therapy devices due to increasing number of people suffering from post-surgery pain will provide lucrative opportunities for market growth.
Key players are focusing on expansion of their brands in emerging regions and manufacturing of advanced products. They also are focusing on acquisition, new product launches and approvals, partnerships, and collaborations to strengthen their global presence.
- In July 2021, F. Hoffmann-La Roche Ltd got approval for Ronapreve™ (casirivimab and imdevimab), for the treatment of patients suffering from mild to moderate COVID-19 via intravenous infusion from Japan’s Ministry of Health, Labour and Welfare (MHLW).
- In 2020, Baxter International Inc. announced that the Evo IQ Syringe Infusion System got the CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA).
- In April 2017, BD announced about the completion of the acquisition of Caesarea Medical Electronics (CME) that is an Israel-based company which is known for infusion pump systems manufacturing.
Scope of the Report
Historical Data Available for
USD Million for Value, Units for Volume
Key Countries Covered
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, Turkey, South Africa, and GCC Countries
Key Segments Covered
Product type, application, end user, and region
Key Companies Profiled
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Key Questions Answered in Report
How much is the home infusion therapy devices market worth?
The home infusion therapy devices market is expected to surpass US$ 2.0 Bn in 2021.
What is the demand outlook of the home infusion therapy devices market?
Home infusion therapy devices are projected to expand at a CAGR of 6.5% between 2021 and 2031.
What are the key trends shaping home infusion therapy devices market?
Technological advancement and launch of user-friendly devices from leading brands are some of the trends that will fuel the demand for home infusion therapy devices.
What is the market share of the top players in the home infusion therapy devices market?
Top players are expected to contribute nearly 85.5% of the overall global market share.
Which are the top 5 countries driving demand for home infusion therapy devices?
U.S., China, Germany, U.K., and Japan are the top 5 countries that are driving the demand for .
At what rate will the sales of home infusion therapy devices rise in Europe?
Europe home infusion therapy devices market is forecast to grow at a CAGR of 6.2% in 2021- 2031.
What is the outlook for home infusion therapy devices market in East Asia?
The East Asia market is set to exhibit robust growth at a CAGR of over 7.3% during the forecast period.
Which companies are key producers of home infusion therapy devices?
Becton, Diciknson & Conmpany, B.Braun Melsungen AG, Baxter International,
Fresenius Kabi, and Terumo Corporation are key producers in this market.
Home Infusion Therapy Devices Market by Category
By Product Type:
- Disposable Elastomeric Pumps
- Insulin Pumps
- PCA Pumps
- Electronic Ambulatory Pumps
- Infusion System Accessories
- Enteral Nutrition
- Parenteral Nutrition
- Antibiotic Administration
By End User:
- Home Care Settings
- Long Term Care Centers
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa (MEA)